Search results for "Central Nervous System Disease"

showing 10 items of 199 documents

EEG-related Functional MRI in Benign Childhood Epilepsy with Centrotemporal Spikes

2003

The localization of epileptic foci is an important issue in children with extratemporal epilepsies. However, the value of noninvasive methods such as the EEG-assisted functional magnetic resonance imaging (fMRI) has not been sufficiently investigated in children. As a model of extratemporal epilepsies, we studied 7 patients aged 5 to 12 (median 10) years with benign childhood epilepsy and centrotemporal (rolandic) spikes. Interictal spikes were recorded during the fMRI acquisition on a MR-compatible battery-powered digital EEG system with 16 channels. The fMRI sequences were correlated off-line with the EEG spikes and analyzed with the software Statistical Parametrical Mapping SPM99. The fM…

MaleChildhood epilepsyElectroencephalographyEEG-fMRICentral nervous system diseaseEpilepsyOxygen ConsumptionImage Processing Computer-AssistedmedicineHumansIctalChildEvoked PotentialsMathematical ComputingBrain Mappingmedicine.diagnostic_testElectroencephalographySignal Processing Computer-AssistedImage Enhancementmedicine.diseaseEpilepsy RolandicMagnetic Resonance ImagingTemporal LobeFunctional imagingNeurologyChild PreschoolFemaleNeurology (clinical)Functional magnetic resonance imagingPsychologyNeuroscienceEpilepsia
researchProduct

rTMS of supplementary motor area modulates therapy-induced dyskinesias in Parkinson disease

2005

The neural mechanisms and circuitry involved in levodopa-induced dyskinesia are unclear. Using repetitive transcranial magnetic stimulation (rTMS) over the supplementary motor area (SMA) in a group of patients with advanced Parkinson disease, the authors investigated whether modulation of SMA excitability may result in a modification of a dyskinetic state induced by continuous apomorphine infusion. rTMS at 1 Hz was observed to markedly reduce drug-induced dyskinesias, whereas 5-Hz rTMS induced a slight but not significant increase.

MaleDyskinesia Drug-InducedApomorphinemedicine.medical_treatmentDopamineNeurological disorderNOCentral nervous system diseaseDegenerative diseasemental disordersNeural PathwaysmedicineHumansAgedSupplementary motor areaDyskinesiabusiness.industryDyskinesia Drug-Induced; Treatment Outcome; Male; Middle Aged; Female; Humans; Parkinson Disease; Motor Cortex; Recovery of Function; Apomorphine; Dopamine Agonists; Neural Pathways; Aged; Transcranial Magnetic Stimulation; DopamineMotor CortexParkinson DiseaseRecovery of FunctionMiddle Agedmedicine.diseaseSMA*Transcranial Magnetic Stimulationnervous system diseasesTranscranial magnetic stimulationApomorphinemedicine.anatomical_structureTreatment OutcomeDyskinesiaDrug-InducedDopamine AgonistsFemaleSettore MED/26 - NeurologiaNeurology (clinical)medicine.symptombusinessNeurosciencemedicine.drug
researchProduct

Medical treatment and medical side effects in urinary incontinence in the elderly

1998

MaleNephrologymedicine.medical_specialtyDrug-Related Side Effects and Adverse ReactionsIncontinencia urinariaUrinary Incontinence StressUrologyUrinary BladderUrinary incontinenceCentral nervous system diseaseInternal medicinemedicineHumansProstatismProstate diseaseAgedMedical treatmentbusiness.industryAge FactorsMuscle Smoothmedicine.diseaseSurgeryUrinary IncontinencePhysical therapyFemalemedicine.symptombusinessWorld Journal of Urology
researchProduct

Gastric α-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology

2005

The progressive degenerative process associated with sporadic Parkinson's disease (sPD) is characterized by formation of alpha-synuclein-containing inclusion bodies in a few types of projection neurons in both the enteric and central nervous systems (ENS and CNS). In the brain, the process apparently begins in the brainstem (dorsal motor nucleus of the vagal nerve) and advances through susceptible regions of the basal mid-and forebrain until it reaches the cerebral cortex. Anatomically, all of the vulnerable brain regions are closely interconnected. Whether the pathological process begins in the brain or elsewhere in the nervous system, however, is still unknown. We therefore used immunocyt…

MaleNervous systemProtein FoldingPathologymedicine.medical_specialtyPrionsModels NeurologicalCentral nervous systemMyenteric PlexusBiologyAxonal TransportCentral nervous system diseaseNeural PathwaysDisease Transmission InfectiousmedicineHumansAgedAged 80 and overInclusion BodiesNeuronsGeneral NeuroscienceBrainParkinson DiseaseVagus NerveSubmucous PlexusMiddle Agedmedicine.diseasemedicine.anatomical_structureDorsal motor nucleusGastric MucosaCerebral cortexForebrainalpha-SynucleinFemaleEnteric nervous systemBrainstemNerve NetNeuroscienceNeuroscience Letters
researchProduct

Choice of reference area in studies of Alzheimer's disease using positron emission tomography with fluorodeoxyglucose-F18

2007

At present, there is still no consensus on the choice of the reference area in positron emission tomography (PET) studies of Alzheimer's disease (AD). In this study, PET scans with fluorodeoxyglucose-F18 were carried out in the following groups of subjects: 47 patients with probable AD, 8 patients with mild cognitive impairment, and 15 age-similar healthy subjects. Scans normalized to the cerebral global mean (CGM), cerebellum (CBL), and the primary sensorimotor cortex (SMC). We evaluated the effect of the different count normalization procedures on the accuracy of (18)F-FDG PET to detect AD-specific metabolic abnormalities (voxel-based group comparison) and to differentiate between patient…

MaleNormalization (statistics)Pathologymedicine.medical_specialtyAdolescentNeuroscience (miscellaneous)Neuropsychological TestsStatistical parametric mappingGyrus CinguliSeverity of Illness IndexCentral nervous system diseaseAlzheimer DiseaseFluorodeoxyglucose F18CerebellumParietal LobemedicineHumansDementiaRadiology Nuclear Medicine and imagingAgedFluorodeoxyglucosemedicine.diagnostic_testbusiness.industryCognitive disorderMotor CortexSomatosensory Cortexmedicine.diseaseTemporal LobeFrontal LobePsychiatry and Mental healthPositron emission tomographyPositron-Emission TomographyFemaleRadiopharmaceuticalsAlzheimer's diseaseCognition DisordersNuclear medicinebusinessPsychologymedicine.drugPsychiatry Research: Neuroimaging
researchProduct

Generalised sensory system abnormalities in amyotrophic lateral sclerosis: a European multicentre study.

2007

International audience; BACKGROUND: Amyotrophic lateral sclerosis (ALS) is defined as a disease of the motor neurones, although several studies indicate involvement of the sensory nervous system. AIM: To evaluate the sensory nerve conduction studies (NCS) in 88 patients with ALS as part of a European multicentre study. METHODS: Seven European clinical neurophysiologists examined consecutive series of ALS patients. The examinations were peer reviewed, and the diagnosis of ALS was confirmed clinically. RESULTS: 20 (22.7%) patients with ALS had sensory NCS abnormalities in at least one nerve. Of those, 11 (12.5% of all patients) obtained an additional peer review diagnosis of electrophysiologi…

MalePathologyNeural Conduction0302 clinical medicineMESH: Aged 80 and overDorsal root ganglionMESH: Neural ConductionAmyotrophic lateral sclerosisMESH: Amyotrophic Lateral SclerosisAged 80 and overMESH: Aged0303 health sciencesMESH: ElectrophysiologyMESH: Middle AgedMESH: Neurons AfferentMiddle AgedElectrophysiologyEuropePsychiatry and Mental healthmedicine.anatomical_structureMESH: Sensation DisordersSensation DisordersFemale[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]PolyneuropathySensory nerveAdultmedicine.medical_specialtyNeuromuscular diseaseShort ReportSensory systemCentral nervous system disease03 medical and health sciencesmedicineHumans[SDV.NEU] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]Neurons AfferentAged030304 developmental biologyMESH: Humansbusiness.industryAmyotrophic Lateral SclerosisMESH: Adultmedicine.diseaseMESH: MaleSurgeryNeurology (clinical)MESH: EuropebusinessMotor neurone diseaseMESH: Female030217 neurology & neurosurgery
researchProduct

Brain Edema and Intracerebral Necrosis Caused by Transcranial Low-Frequency 20-kHz Ultrasound

2006

Background and Purpose— Ultrasound-accelerated thrombolysis is a promising approach toward acute stroke treatment. In previous in vitro studies, we demonstrated enhanced thrombus destruction induced by 20-kHz ultrasound. However, little is known about biological interactions of low-frequency ultrasound with brain tissue. The aim of this in vivo MRI study was to assess safety aspects of transcranial low-frequency ultrasound in rats. Methods— The cranium of 33 male Wistar rats was sonificated for 20 minutes (20-kHz continuous wave). Power output was varied between 0 and 2.6 W/cm 2 . Tympanal and rectal temperature was monitored. Diffusion-weighted imaging and T2-weighted imaging was performe…

MalePathologymedicine.medical_specialtyBrain EdemaBrain IschemiaCerebral edemaBrain ischemiaCentral nervous system diseaseNecrosisIn vivomedicineAnimalsThrombolytic TherapyUltrasonicsRats WistarThrombusStrokeAdvanced and Specialized Nursingmedicine.diagnostic_testbusiness.industryUltrasoundDose-Response Relationship RadiationMagnetic resonance imagingmedicine.diseaseMagnetic Resonance ImagingRatsRadiographyNeurology (clinical)Cardiology and Cardiovascular MedicinebusinessStroke
researchProduct

Stage-dependent and sector-specific neuronal loss in hippocampus during Alzheimer's disease

2000

Recent stereological studies documented a severe loss of hippocampal neurons in end-stage Alzheimer's disease. The development of the disease, however, is progressive and slow, over clinically inconspicuous decades. The Braak-staging system distinguishes six histopathological stages some of which are not accompanied by clinical symptoms. We analyzed hippocampal cell loss in correlation to Braak stages. Neuron numbers were determined with unbiased stereological principles in a defined subportion of the hippocampus of 28 subjects. There were no age-dependent neuronal losses in any of the hippocampal subdivisions examined. Compared to stage I, pyramidal cell loss in CA1 was reduced by 33% in s…

MalePathologymedicine.medical_specialtyHippocampusCell CountStereologyHippocampal formationBiologyHippocampusPathology and Forensic MedicineCentral nervous system diseaseCellular and Molecular NeuroscienceAlzheimer DiseasemedicineHumansAgedAged 80 and overNeuronsSubiculumMiddle Agedmedicine.diseasemedicine.anatomical_structurenervous systemFemaleNeurology (clinical)NeuronPyramidal cellAlzheimer's diseaseActa Neuropathologica
researchProduct

Moderate controlled cortical contusion in pigs: effects on multi-parametric neuromonitoring and clinical relevance.

2004

Over the last decade, routine neuromonitoring of ICP and CPP has been extended with new on-line techniques such as microdialysis, tissue oxygen (ptiO(2)), acid-base balance (ptiCO(2), pH) and CBF measurements, which so far have not lead to clear-cut therapy approaches in the neurointensive care unit. This is partially due to the complex pathophysiology following a wide-range of brain injuries, and the lack of suitable animal models allowing simultaneous, clinically relevant neuromonitoring under controlled conditions. Therefore, a controlled cortical impact (CCI) model in large animals (pig) has been developed. After placement of microdialysis, ptiO(2), temperature and ICP catheters, an uni…

MalePathologymedicine.medical_specialtyMicrodialysisIntracranial PressureSwineGlutamic AcidBrain EdemaBody TemperatureCentral nervous system diseaseText miningOxygen ConsumptionPyruvic AcidmedicineAnimalsClinical significanceLactic AcidCell damageMonitoring Physiologicbusiness.industryGlutamate receptormedicine.diseasePathophysiologyDisease Models Animalmedicine.anatomical_structureGlucoseCerebral cortexAnesthesiaBrain InjuriesNeurology (clinical)businessJournal of neurotrauma
researchProduct

Association of elevated phospho-tau levels with alzheimer-typical 18F-Fluoro-2-Deoxy-D-Glucose positron emission tomography findings in patients with…

2003

Abstract Background Mild cognitive impairment is considered to be a transitional stage between normal aging and dementia. Phosphorylated tau protein in cerebrospinal fluid and even more decrements of cerebral glucose metabolism in parietal, temporal, or cingulate regions have shown favorable specificity for the diagnosis of Alzheimer dementia and could be useful supplementary tools to determine Alzheimer pathology in early stages. Methods We measured cerebrospinal fluid tau phosphorylated at threonine 181 protein, cerebrospinal fluid total tau, and cerebral glucose metabolism using 18F-fluoro-2-deoxy-D-glucose positron emission tomography in 16 patients with mild cognitive impairment and ag…

MalePathologymedicine.medical_specialtyTau proteintau ProteinsNeuropsychological TestsStatistics NonparametricCentral nervous system diseasechemistry.chemical_compoundCerebrospinal fluidAlzheimer DiseaseFluorodeoxyglucose F18Predictive Value of Testsmental disordersmedicineHumansDementiaPhosphorylationBiological PsychiatryAgedAged 80 and overBrain ChemistryBrain Mappingmedicine.diagnostic_testbiologybusiness.industryMiddle Agedmedicine.diseaseGlucosechemistryPositron emission tomographyCase-Control Studiesbiology.proteinBiomarker (medicine)FemaleAlzheimer's diseaseCognition Disorders2-Deoxy-D-glucosebusinessTomography Emission-ComputedBiological Psychiatry
researchProduct